What are the risks of using SSRIs during pregnancy on fetal development?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18428020
Cited by: 0

Abstract

Using SSRIs during pregnancy may slightly increase certain risks, such as PPHN, but generally poses a low absolute risk of congenital malformations or neurodevelopmental disorders, underlining the importance of continued research and careful clinical evaluation.

Fields of Study & Subjects

Pregnancy and Medication Impact Maternal Mental Health During Pregnancy and Postpartum Prenatal Substance Exposure Effects

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 January 2026